Capital Research Global Investors Artivion, Inc. Transaction History

Capital Research Global Investors

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2020 Feb 12, 2021	SELL	$16.76 - $23.74 $8.1 Million - $11.5 Million	-483,112 Closed	0 $0
Q3 2020 Nov 13, 2020	SELL	$16.35 - $21.4 $40.3 Million - $52.7 Million	-2,464,878 Reduced 83.61%	483,112 $8.92 Million
Q1 2020 May 15, 2020	BUY	$14.66 - $30.57 $20.6 Million - $43.1 Million	1,408,403 Added 91.48%	2,947,990 $49.9 Million
Q4 2019 Feb 18, 2020	BUY	$22.45 - $27.09 $5.47 Million - $6.6 Million	243,467 Added 18.78%	1,539,587 $41.7 Million
Q2 2019 Aug 14, 2019	SELL	$27.55 - $32.39 $46.5 Million - $54.7 Million	-1,689,628 Reduced 56.59%	1,296,120 $38.8 Million
Q1 2019 May 15, 2019	BUY	$25.85 - $30.47 $15.9 Million - $18.7 Million	613,248 Added 25.85%	2,985,748 $87.1 Million
Q4 2018 Feb 14, 2019	SELL	$25.76 - $34.03 $11.6 Million - $15.3 Million	-450,577 Reduced 15.96%	2,372,500 $67.3 Million
Q3 2018 Nov 14, 2018	SELL	$28.6 - $35.75 $6.64 Million - $8.3 Million	-232,174 Reduced 7.6%	2,823,077 $99.4 Million
Q4 2017 Feb 14, 2018	BUY	$18.65 - $23.85 $3.69 Million - $4.72 Million	197,802 Added 6.92%	3,055,251 $58.5 Million
Q3 2017 Nov 14, 2017	BUY	$18.85 - $23.05 $53.9 Million - $65.9 Million	2,857,449	2,857,449 $64.9 Million

178

36.1M

33K

900

Ticker AORT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 40,316,100
Market Cap $1.25B
Description
Artivion Inc. manufactures, processes, and distributes medical devices and implantable human tissues worldwide. The company offers BioGlue, a polymer consisting of bovine blood protein and an agent for cross-linking proteins for cardiac, vascular, neurologic, and pulmonary procedures; cardiac preservation services; PhotoFix, a bovine pericardial...

Get notified when there are updates to the investment portfolio of Capital Research Global Investors, based on Form 13F filings with the SEC.

Stay updated on Capital Research Global Investors with notifications on news.